Astera Labs (NASDAQ:ALAB) Posts Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Astera Labs (NASDAQ:ALABGet Free Report) issued its quarterly earnings data on Tuesday. The company reported $0.33 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.05, Briefing.com reports. Astera Labs had a negative net margin of 21.05% and a negative return on equity of 10.40%. The business had revenue of $159.44 million during the quarter, compared to the consensus estimate of $151.55 million. During the same period in the prior year, the firm posted $0.10 EPS. The firm’s quarterly revenue was up 144.1% compared to the same quarter last year. Astera Labs updated its Q2 2025 guidance to 0.320-0.330 EPS.

Astera Labs Price Performance

Shares of NASDAQ ALAB opened at $71.22 on Thursday. Astera Labs has a 1 year low of $36.22 and a 1 year high of $147.39. The firm has a 50-day moving average of $64.21 and a 200 day moving average of $91.37. The stock has a market cap of $11.75 billion, a P/E ratio of -41.17, a price-to-earnings-growth ratio of 6.18 and a beta of 0.33.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 target price for the company in a research report on Tuesday, January 28th. Raymond James assumed coverage on shares of Astera Labs in a research report on Friday, March 14th. They issued an “outperform” rating and a $82.00 target price for the company. Barclays boosted their target price on Astera Labs from $70.00 to $75.00 and gave the stock an “overweight” rating in a research report on Wednesday. Citigroup reduced their target price on shares of Astera Labs from $120.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, April 14th. Finally, Northland Capmk raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $100.85.

Get Our Latest Stock Report on ALAB

Insider Transactions at Astera Labs

In related news, CEO Jitendra Mohan sold 350,680 shares of the company’s stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $89.51, for a total transaction of $31,389,366.80. Following the completion of the sale, the chief executive officer now owns 2,353,655 shares in the company, valued at approximately $210,675,659.05. This represents a 12.97 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Manuel Alba sold 63,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $63.37, for a total transaction of $3,992,310.00. Following the sale, the director now owns 444,863 shares of the company’s stock, valued at $28,190,968.31. This trade represents a 12.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 633,990 shares of company stock valued at $54,235,012 in the last quarter.

Astera Labs Company Profile

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Further Reading

Earnings History for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.